Related Experiment Video

Updated: Aug 5, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells

E S Pizer1, C Jackisch, F D Wood

  • 1Division of Molecular Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

Cancer Research
|June 15, 1996
PubMed

Insights

Fatty acid synthase inhibition by cerulenin effectively targets advanced human epithelial cancers. This approach halts cancer cell growth and induces apoptosis, offering a promising new strategy for antineoplastic therapy.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Advanced human epithelial malignancies lack selective molecular targets for antineoplastic therapy.
  • Elevated fatty acid synthase (FAS) expression is observed in breast, ovarian, endometrial, colorectal, and prostate cancers.
  • Cerulenin, a noncompetitive FAS inhibitor, shows potential for cancer treatment.

Purpose of the Study:

  • To investigate the efficacy of cerulenin as a metabolic inhibitor targeting fatty acid biosynthesis in human breast cancer cells.
  • To evaluate the impact of cerulenin on cancer cell growth, clonogenic capacity, and apoptosis.

Main Methods:

  • Treatment of human breast cancer cells with cerulenin.
  • Assessment of fatty acid synthesis inhibition.
  • Evaluation of clonogenic capacity.
  • Analysis of DNA fragmentation and morphological changes indicative of apoptosis.

Main Results:

  • Cerulenin treatment rapidly inhibited fatty acid synthesis within 6 hours.
  • Loss of clonogenic capacity was observed within the same 6-hour interval.
  • DNA fragmentation and apoptotic morphological changes were induced by cerulenin.

Conclusions:

  • Targeting fatty acid synthase with cerulenin is a viable strategy for treating advanced human epithelial cancers.
  • Cerulenin demonstrates rapid and effective inhibition of cancer cell proliferation and induction of apoptosis.
  • This metabolic targeting approach offers a novel therapeutic avenue for specific cancer types.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death08:26

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death

Published on: October 31, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...